These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
774 related articles for article (PubMed ID: 10030325)
1. Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial. Hansson L; Lindholm LH; Niskanen L; Lanke J; Hedner T; Niklason A; Luomanmäki K; Dahlöf B; de Faire U; Mörlin C; Karlberg BE; Wester PO; Björck JE Lancet; 1999 Feb; 353(9153):611-6. PubMed ID: 10030325 [TBL] [Abstract][Full Text] [Related]
2. Reduced cardiovascular morbidity and mortality in hypertensive diabetic patients on first-line therapy with an ACE inhibitor compared with a diuretic/beta-blocker-based treatment regimen: a subanalysis of the Captopril Prevention Project. Niskanen L; Hedner T; Hansson L; Lanke J; Niklason A; Diabetes Care; 2001 Dec; 24(12):2091-6. PubMed ID: 11723089 [TBL] [Abstract][Full Text] [Related]
3. Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study. Hansson L; Hedner T; Lund-Johansen P; Kjeldsen SE; Lindholm LH; Syvertsen JO; Lanke J; de Faire U; Dahlöf B; Karlberg BE Lancet; 2000 Jul; 356(9227):359-65. PubMed ID: 10972367 [TBL] [Abstract][Full Text] [Related]
4. Effect of angiotensin-converting enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPP) randomized trial. The Captopril Prevention Project (CAPP) Study Group. Curr Hypertens Rep; 1999 Dec; 1(6):466-7. PubMed ID: 11041675 [No Abstract] [Full Text] [Related]
5. [Clinical study of the month. The CAPPP study: "The Captopril Prevention Project"]. Scheen AJ Rev Med Liege; 1999 Mar; 54(3):197-9. PubMed ID: 10321112 [TBL] [Abstract][Full Text] [Related]
6. The Captopril Prevention Project (CAPPP) in hypertension--baseline data and current status. Hansson L; Hedner T; Lindholm L; Niklason A; Luomanmäki K; Niskanen L; Lanke J; Dahlöf B; de Faire U; Mörlin C; Karlberg BE; Wester PO; Björck JE Blood Press; 1997 Nov; 6(6):365-7. PubMed ID: 9495662 [TBL] [Abstract][Full Text] [Related]
7. Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial. Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan. Dickstein K; Kjekshus J; Lancet; 2002 Sep; 360(9335):752-60. PubMed ID: 12241832 [TBL] [Abstract][Full Text] [Related]
9. Cardiovascular events in elderly patients with isolated systolic hypertension. A subgroup analysis of treatment strategies in STOP-Hypertension-2. Ekbom T; Linjer E; Hedner T; Lanke J; De Faire U; Wester PO; Dahlöf B; Scherstén B Blood Press; 2004; 13(3):137-41. PubMed ID: 15223721 [TBL] [Abstract][Full Text] [Related]
10. The Captopril Prevention Project: a prospective intervention trial of angiotensin converting enzyme inhibition in the treatment of hypertension. The CAPPP Group. J Hypertens; 1990 Nov; 8(11):985-90. PubMed ID: 1981218 [TBL] [Abstract][Full Text] [Related]
11. Development of diabetes is retarded by ACE inhibition in hypertensive patients--a subanalysis of the Captopril Prevention Project (CAPPP). Niklason A; Hedner T; Niskanen L; Lanke J; J Hypertens; 2004 Mar; 22(3):645-52. PubMed ID: 15076172 [TBL] [Abstract][Full Text] [Related]
13. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Dahlöf B; Sever PS; Poulter NR; Wedel H; Beevers DG; Caulfield M; Collins R; Kjeldsen SE; Kristinsson A; McInnes GT; Mehlsen J; Nieminen M; O'Brien E; Ostergren J; Lancet; 2005 Sep 10-16; 366(9489):895-906. PubMed ID: 16154016 [TBL] [Abstract][Full Text] [Related]
14. The Hypertension Optimal Treatment study and the importance of lowering blood pressure. Hansson L J Hypertens Suppl; 1999 Feb; 17(1):S9-13. PubMed ID: 10340838 [TBL] [Abstract][Full Text] [Related]
15. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension. Xue H; Lu Z; Tang WL; Pang LW; Wang GM; Wong GW; Wright JM Cochrane Database Syst Rev; 2015 Jan; 1():CD008170. PubMed ID: 25577154 [TBL] [Abstract][Full Text] [Related]
16. Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study. Hansson L; Lindholm LH; Ekbom T; Dahlöf B; Lanke J; Scherstén B; Wester PO; Hedner T; de Faire U Lancet; 1999 Nov; 354(9192):1751-6. PubMed ID: 10577635 [TBL] [Abstract][Full Text] [Related]
18. Therapeutic benefits of ACE inhibitors and other antihypertensive drugs in patients with type 2 diabetes. Pahor M; Psaty BM; Alderman MH; Applegate WB; Williamson JD; Furberg CD Diabetes Care; 2000 Jul; 23(7):888-92. PubMed ID: 10895836 [TBL] [Abstract][Full Text] [Related]
19. Effects of early treatment with captopril and metoprolol singly or together on six-month mortality and morbidity after acute myocardial infarction. Results of the RIMA (Rimodellamento Infarto Miocardico Acuto) study. The RIMA researchers. Coletta C; Ricci R; Ceci V; Seccareccia F; Rulli F; Mazzuca V; Putini RL; Salustri A; Bottero G; Pasquale M G Ital Cardiol; 1999 Feb; 29(2):115-24; discussion 125-9. PubMed ID: 10088066 [TBL] [Abstract][Full Text] [Related]
20. The Role of Beta-Blockers in the Treatment of Hypertension. Cruickshank JM Adv Exp Med Biol; 2017; 956():149-166. PubMed ID: 27957711 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]